MGRX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Mangoceuticals Inc (MGRX) is not a strong buy for a beginner, long-term investor at this time. The lack of positive trading trends, weak financial performance, and absence of significant catalysts make it unsuitable for immediate investment. Additionally, the pre-market price drop and no strong trading signals further suggest holding off on this stock.
The MACD is positive and expanding, indicating a bullish momentum. However, the RSI is in the neutral zone at 75.162, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level (0.4), with resistance at 0.467 and support at 0.332.
NULL identified. No recent news or significant insider/hedge fund activity.
Pre-market price dropped by -2.52%. Financial performance shows declining revenue and EPS, with no recent news or catalysts to drive positive sentiment.
In Q4 2025, revenue dropped by -10.34% YoY to 94360. Net income improved but remains negative at -3063567, up 57.24% YoY. EPS dropped significantly by -70.27% YoY to -0.22. Gross margin improved but is still negative at -1139.43%. Overall, the financials are weak and do not support a strong investment case.
No recent analyst ratings or price target changes available.
